Orbital Myositis Diagnosis: An Expert Guide for Accurate Identification

Decoding Orbital Myositis: A Diagnostic Algorithm for Effective Treatment

Orbital myositis, particularly its idiopathic form (Idiopathic Orbital Myositis or IOM), presents a diagnostic puzzle in ophthalmology and related fields. As a rare inflammatory condition targeting the extraocular muscles, accurate and timely Orbital Myositis Diagnosis is crucial for effective patient management and preventing potential complications. This article, drawing upon clinical expertise and established treatment algorithms, aims to provide a comprehensive guide to diagnosing orbital myositis, ensuring clinicians are well-equipped to navigate this diagnostic challenge.

Understanding Orbital Myositis: Initial Presentation and Clinical Clues

The journey to an orbital myositis diagnosis often begins with recognizing the initial signs and symptoms. Patients typically present with a constellation of complaints, most notably “eye swelling.” In the case of a 19-year-old female patient, her symptoms included a week-long headache, a day of noticeable left “eye swelling,” and pain exacerbated by eye movements. Accompanying symptoms can include mild horizontal binocular diplopia, particularly on side gazes, and blurred vision in the affected eye. It’s important to note that while these symptoms are indicative, they are not exclusive to orbital myositis, necessitating a thorough differential diagnosis process.

Initially, patients might be misdiagnosed with more common conditions such as sinusitis, as in the case mentioned where the primary care provider attributed the headache to sinus issues. However, persistent headache and the subsequent development of eye swelling should raise suspicion for orbital pathology. Emergency department evaluations may include computed tomography (CT) scans, which can reveal characteristic features like an enlarged extraocular muscle, such as the medial rectus muscle in the presented case. Crucially, a comprehensive history, including the absence of recent trauma, autoimmune disease history, thyroid abnormalities, photophobia, fevers, or rash, aids in narrowing down the potential diagnoses.

Past ocular and medical history, family history, and social history, although seemingly less directly related, contribute to the overall clinical picture. In this case, the patient’s myopia, past cholecystectomy, polycystic ovarian syndrome, and negative family history for autoimmune or ophthalmic diseases provide context but are not primary diagnostic indicators for orbital myositis.

Ocular Examination: Key Findings in Orbital Myositis Diagnosis

A meticulous ocular examination is paramount in the orbital myositis diagnosis process. Visual acuity tests may show mild reduction, as seen in the case with 20/25-1 vision in the right eye and 20/25-2 in the left eye without pinhole improvement, suggesting the issue is not purely refractive. Ocular motility assessment can reveal restrictions, such as the -2 adduction noted in the left eye of the patient, indicating muscle involvement. While intraocular pressure typically remains within normal limits, exophthalmometry may reveal proptosis, with the presented case showing 20.5 mm protrusion in the left eye compared to 18 mm in the right.

External examination often reveals periocular edema and proptosis in the affected eye. Slit lamp examination, while primarily aimed at anterior segment evaluation, can show eyelid edema and erythema, further supporting external inflammation. Importantly, dilated fundus examination is usually normal in orbital myositis, helping to differentiate it from conditions primarily affecting the retina or optic nerve.

Laboratory and Imaging: Cornerstones of Orbital Myositis Diagnosis

While clinical presentation and ocular examination provide strong clues, laboratory and imaging investigations are indispensable for confirming an orbital myositis diagnosis and excluding other conditions.

Initial laboratory workup should include a basic metabolic panel (BMP), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), thyroid-stimulating hormone (TSH), free T4, and thyroid-stimulating immunoglobulin (TSI). Elevated ESR and CRP, as seen in the case (ESR of 21 mm/hour and CRP of 1.2), are indicative of inflammation but are not specific to orbital myositis. Thyroid function tests, including TSH, free T4, and TSI, are crucial to rule out thyroid-associated orbitopathy (TAO), a significant differential diagnosis. In euthyroid patients, TSI is particularly useful for excluding TAO.

Figure 1: Axial and coronal CT images showing enlargement of the left medial rectus muscle, a key indicator for orbital myositis diagnosis.

Imaging plays a pivotal role in orbital myositis diagnosis. CT imaging of the orbits, particularly without contrast, is effective in demonstrating extraocular muscle enlargement. As seen in Figure 1 from the original article, CT scans clearly illustrate the marked enlargement of the left medial rectus muscle and tendon, accompanied by adjacent fat stranding. Importantly, CT imaging helps exclude other orbital pathologies such as abscesses, posterior scleritis, or lacrimal gland enlargement, and confirms the absence of sinus involvement.

While CT is valuable, magnetic resonance imaging (MRI) of the orbits with and without contrast and fat suppression is often preferred for its superior soft tissue detail. MRI can more sensitively detect muscle inflammation and differentiate orbital myositis from other orbital conditions. Orbital ultrasound can be a quicker and more cost-effective alternative if MRI or CT are not readily available or contraindicated.

Radiologically, orbital myositis diagnosis is supported by the unilateral or bilateral thickening and enhancement of the affected extraocular muscles, frequently involving the myotendinous insertion. This contrasts with TAO, where muscle enlargement typically spares the tendon.

Differential Diagnosis: Distinguishing Orbital Myositis from Mimicking Conditions

A critical aspect of orbital myositis diagnosis is differentiating it from a range of conditions that can mimic its presentation. The differential diagnosis is broad and includes:

• Thyroid-Associated Orbitopathy (TAO): Perhaps the most crucial differential, TAO shares clinical features like proptosis and extraocular muscle enlargement. However, TAO often presents with bilateral involvement and typically spares the muscle tendons radiologically. Thyroid function tests and TSI levels are vital in distinguishing TAO.
• Orbital Cellulitis and Pre-septal Cellulitis: Infections of the orbit or periocular tissues can cause swelling, pain, and redness. Fever, leukocytosis on CBC, and clinical context of infection (e.g., sinusitis, skin infection) help differentiate cellulitis. Imaging, particularly CT, in cellulitis may show diffuse orbital inflammation or abscess formation, unlike the muscle-specific enlargement in orbital myositis.
• Myositis Associated with Systemic Autoimmune Disease: Systemic conditions like rheumatoid arthritis, lupus, or granulomatosis with polyangiitis (GPA) can manifest with orbital myositis. A comprehensive review of systems, ANA, RF, and ANCA screen can help identify underlying systemic autoimmune diseases.
• Carotid-Cavernous Fistula: This vascular abnormality can cause proptosis, chemosis, and pulsatile tinnitus. Clinical examination may reveal a bruit, and imaging, such as MRI or CT angiography, can confirm the fistula.
• IgG4-Related Disease: This systemic fibro-inflammatory condition can affect the orbit, including extraocular muscles. Serum IgG4 levels and orbital biopsy may be necessary for diagnosis in suspected cases.
• Optic Neuritis: While primarily affecting the optic nerve, optic neuritis can present with orbital pain exacerbated by eye movement and vision changes. However, optic neuritis typically involves visual field defects, afferent pupillary defect, and optic disc abnormalities on fundoscopy, which are not typical in orbital myositis unless there is secondary optic nerve compression.
• Tolosa-Hunt Syndrome: This painful ophthalmoplegia syndrome is characterized by granulomatous inflammation in the cavernous sinus or superior orbital fissure. While it can affect extraocular muscles and cause pain, Tolosa-Hunt syndrome typically involves multiple cranial nerve palsies and may respond to steroids, similar to orbital myositis, making differentiation challenging. Imaging focusing on the cavernous sinus region can be helpful.
• Orbital Lymphoma and Other Neoplasms: Orbital tumors can mimic orbital myositis by causing proptosis and muscle involvement. The absence of pain, progressive rather than acute onset, and atypical imaging features (e.g., mass lesion rather than diffuse muscle enlargement) should raise suspicion for neoplasm, necessitating orbital biopsy for definitive diagnosis.
• Sarcoidosis: Systemic sarcoidosis can involve the orbit and extraocular muscles. Chest X-ray, ACE levels, and biopsy of other affected tissues can aid in diagnosing sarcoidosis.

Treatment Algorithm and Its Diagnostic Implication

While this article primarily focuses on orbital myositis diagnosis, the treatment approach also has diagnostic implications. Idiopathic orbital myositis typically responds dramatically to systemic corticosteroids. A rapid clinical response to high-dose corticosteroids (e.g., oral prednisone 1 mg/kg/day) strongly supports the diagnosis of IOM. In the presented case, the patient’s symptoms fully resolved within two days of starting 80 mg oral prednisone, reinforcing the diagnosis.

Conversely, lack of response or atypical response to corticosteroids should prompt reconsideration of the diagnosis and further investigation into alternative conditions in the differential. The treatment algorithm, starting with NSAIDs for mild cases and progressing to corticosteroids for moderate to severe cases, serves not only as a therapeutic guideline but also as a diagnostic tool.

Conclusion: Achieving Accurate Orbital Myositis Diagnosis for Optimal Patient Care

Accurate orbital myositis diagnosis requires a systematic approach, integrating clinical presentation, thorough ocular examination, targeted laboratory investigations, and crucial imaging studies. A comprehensive differential diagnosis process is essential to exclude mimicking conditions, particularly thyroid-associated orbitopathy and orbital cellulitis. The positive response to corticosteroids further supports the diagnosis of idiopathic orbital myositis. By adhering to a structured diagnostic algorithm, clinicians can confidently and effectively diagnose orbital myositis, paving the way for timely and appropriate management, ultimately improving patient outcomes.

References

1. Gordon LK. Orbital inflammatory disease: a diagnostic and therapeutic challenge. Eye (Lond). 2006;20(10):1196-206.
2. Montagnese F, Wenninger S, Schoser B. “Orbiting around” the orbital myositis: clinical features, differential diagnosis and therapy. J Neurol. 2015.
3. Kazuo K, Fujikado T, Ohmi G, Hosohata J, Tano Y. Value of thyroid stimulating antibody in the diagnosis of thyroid associated ophthalmopathy of euthyroid patients. Br J Ophthalmol. 1997;81(12):1080-3.
4. Dragan LR, Seiff SR, Lee DC. Longitudinal correlation of thyroid-stimulating immunoglobulin with clinical activity of disease in thyroid-associated orbitopathy. Ophthal Plast Reconstr Surg. 2006;22(1):13-9.
5. Kubota T, Kano H. Assessment of inflammation in idiopathic orbital myositis with fat-suppressed T2-weighted magnetic resonance imaging. Am J Ophthalmol. 2007;143(4):718-20.
6. Schoser BG. Ocular myositis: diagnostic assessment, differential diagnoses, and therapy of a rare muscle disease – five new cases and review. Clin Ophthalmol. 2007;1(1):37-42.
7. Martins WA, Marrone LC, Saute R, Becker J, Vargas JA, da Costa Vargas JF, et al. Ocular myositis: insights into recurrence and semiological presentation. Int J Neurosci. 2015;125(9):711-5.
8. Mannor GE, Rose GE, Moseley IF, Wright JE. Outcome of orbital myositis. Clinical features associated with recurrence. Ophthalmology. 1997;104(3):409-13; discussion, 14.
9. Yan J, Wu P. Idiopathic orbital myositis. J Craniofac Surg. 2014;25(3):884-7.
10. Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130(4):492-513.
11. Kermani TA, Warrington KJ, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, et al. Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study. J Rheumatol. 2015;42(7):1213-7.
12. Weyand CM, Fulbright JW, Hunder GG, Evans JM, Goronzy JJ. Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity. Arthritis Rheum. 2000;43(5):1041-8.
13. Takakura A, Kirkeby K, Earle K, Silkiss RZ. Predicting the Development of Orbitopathy in Graves Thyroidopathy Patients: The Potential Role of TSI Testing. Ophthal Plast Reconstr Surg. 2015;31(5):369-72.
14. Narum S, Westergren T, Klemp M. Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis. BMJ Open. 2014;4(5):e004587.
15. Costa RM, Dumitrascu OM, Gordon LK. Orbital myositis: diagnosis and management. Curr Allergy Asthma Rep. 2009;9(4):316-23.
16. El Nasser AMA. Local steroid injection for management of different types of acute idiopathic orbital inflammation: an 8-year study. Ophthal Plast Reconstr Surg. 2013;29(4):286-9.